{"id":"W2260397345","doi":"10.1200/jco.2006.24.18_suppl.14040","title":"Phase II study of PS-341 (bortezomib) with or without irinotecan in patients (pts) with advanced gastric adenocarcinomas (AGA)","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Irinotecan; Bolus (digestion); Surgery; Internal medicine; Gastroenterology; Adenocarcinoma; Phases of clinical research; Bortezomib; Urology; Cancer; Toxicity; Colorectal cancer; Multiple myeloma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001234997,0.001121514,0.00164042,0.0003814723,0.0004027055,0.0007178721,0.0005438378,0.0008931175,0.002392537],"category_scores_gemma":[0.0006535875,0.0004842661,0.0007232212,0.0003986295,0.001014738,0.000562244,0.0003892927,0.002405141,0.0005589331],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000757229,"about_ca_system_score_gemma":0.001740915,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008232123,"about_ca_topic_score_gemma":0.001869088,"domain_scores_codex":[0.9996834,0.0001515837,0.00001759904,0.00005380967,0.00003455155,0.00005903302],"domain_scores_gemma":[0.9994636,0.00009051384,0.00007942122,0.00002967573,0.00002588047,0.0003108876],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6549229,0.1071221,0.02019247,0.0009379184,0.001134588,0.0007586826,0.0006167811,0.003959939,0.09942122,0.0003521034,0.003012593,0.1075688],"study_design_scores_gemma":[0.2931315,0.6794514,0.01778878,0.00002831602,0.0004079411,0.0004549197,0.00007895509,0.001160045,0.004689783,0.0001328902,0.002653968,0.00002152009],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9967037,0.000992185,0.0002355522,0.0002314286,0.00004332148,0.0009726659,0.0002446386,0.00002895415,0.0005475853],"genre_scores_gemma":[0.9936838,0.001139006,0.001230571,0.0004796009,0.0001433119,0.001350453,0.0008134423,0.00001172756,0.001148069],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002392537,"threshold_uncertainty_score":0.008003831,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06678361614358176,"score_gpt":0.4275296963986873,"score_spread":0.3607460802551055,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}